Creative Medical (CELZ) news

Creative Medical Technology - Patent application expands IP protection for Ultrasome platform

Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for a patent application titled “Suppression of Diabetes Using Exosomes” (U.S. Application No. 17/931,868). Once issued, the patent will expand the…

Creative Medical Technology - Files new U.S. provisional patent application

Creative Medical Technology has recently filed a new U.S. provisional patent application, marking a strategic step in its intellectual property development. While specific details of the application remain confidential, the move aligns with broader industry trends emphasizing robust IP strategies .…

Creative Medical Technology - patent to extend IP protection for MyelocelZ platform in type 1 diabetes

Creative Medical Technology Holdings, Inc. (CELZ) has announced a development related to its intellectual property (IP) portfolio, specifically for its MyelocelZ platform, which is being explored for the treatment of type 1 diabetes. The company has taken steps to extend IP protection for this…

Creative Medical Technology - receives USPTO notice of allowance for exosome-based Type 1 diabetes patent

Creative Medical Technology Holdings announces agreements for exercise of warrants for $4.5 million gross proceeds

Creative Medical Technology Holdings, Inc. (Nasdaq: CELZ) has announced agreements with certain holders of its existing warrants for the immediate exercise of outstanding warrants to raise approximately $4.2 million in gross proceeds. The transaction involves the exercise of warrants to purchase up…